drugset
drugset / Trial / NCT00366080

Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy

NCT00366080 ↗

Phase 2 Terminated 69 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness and safety of the drug GSK189254 in treating patients with narcolepsy.

Timeline

Start
2006-11
Primary completion
2008-01
Completion
2008-01

Outcome

Outcome not reported

Stopped: “Study was terminated based on the interim results of a futility test.”

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK189254 Small molecule — —

Indications

narcolepsy